(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CHACMPEP

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CHACMPEP

ST13

US500000098630300

Class

5

Filing

98630300

Registration

8098447

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

19

Latest update

01/13/2026

Trademark type

Word

Nice classes

5

Filing date

07/02/2024

Registration date

01/13/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/13/2026

Last transaction

01/13/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

Drawing code

4

Owner type

99

Owner location

SHANGHAI, CN

Examiner

KIM,SOPHIA SUJIN

Law office

O70

Current location

TMO LAW OFFICE 134

Holders and representatives

Holders

RJK Biopharma Inc.

Representatives

Alex Patel Patel IP, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Biological preparations for the treatment of neurodegenerative diseasesAmyotrophic Lateral SclerosisParkinson's DiseaseAlzheimer's DiseaseCataractdry Age-related Macular Degeneration; Biological tissue cultures for medical purposes; Collyrium; Medicinal drinks; Amino acids for medical purposes; Diagnostic preparations for medical purposes; Enzymes for medical purposes; Pharmaceutical preparations for the treatment and prevention of neurodegenerative diseasesAmyotrophic Lateral SclerosisParkinson's DiseaseAlzheimer's DiseaseCataractdry Age-related Macular Degeneration; Enzyme preparations for medical purposes; Dietetic foods adapted for medical purposes; All the above-mentioned goods relating to neurodegenerative diseasesAmyotrophic Lateral SclerosisParkinson's DiseaseAlzheimer's DiseaseCataractdry Age-related Macular Degeneration

Publications

History of USPTO decisions and trademark events.

19 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/13/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

01/13/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/25/2025

PUBO

PUBLISHED FOR OPPOSITION

11/25/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/19/2025

OTHE

CASE RETURNED TO EXAMINATION

10/20/2025

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

10/17/2025

PCBG

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

10/17/2025

APET

ASSIGNED TO PETITION STAFF

10/16/2025

IUCN

NOTICE OF ALLOWANCE CANCELLED

09/18/2025

TPAD

TEAS PETITION TO AMEND BASIS RECEIVED

09/04/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/18/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/21/2025

PUBO

PUBLISHED FOR OPPOSITION

01/21/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/15/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/29/2024

DOCK

ASSIGNED TO EXAMINER

12/27/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/02/2024

NWAP

NEW APPLICATION ENTERED

07/02/2024

Continuous trademark protection

Get notified about every new filing that threatens CHACMPEP or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.